Jason Trubiano to Inpatients
This is a "connection" page, showing publications Jason Trubiano has written about Inpatients.
Connection Strength
0.153
-
Risk factors for readmission following inpatient management of COVID-19 in a low-prevalence setting. Intern Med J. 2021 05; 51(5):821-823.
Score: 0.071
-
Antimicrobial anaphylaxis: the changing face of severe antimicrobial allergy. J Antimicrob Chemother. 2020 01 01; 75(1):229-235.
Score: 0.065
-
A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients. J Med Virol. 2021 May; 93(5):3261-3267.
Score: 0.018